The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects
Clinical trial NCT04202952 · COMPLETED
Trial details
- NCT number
- NCT04202952
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-06
- Primary completion
- 2020-08-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.